The invention provides an immunostimulatory nucleic acid. In certain embodiments according to this aspect of the invention, the sequence of the immunostimulatory oligonucleotide and/or immunomer is at least partially self-complementary.

 
Web www.patentalert.com

< Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics

< Nuclease resistant double-stranded ribonucleic acid

> Immunomodulatory oligonucleotides

> Inclusion complexes of rosiglitazone
~ 00258